Biotechnology

Nascent Biotech, Inc.

Nascent Biotech, Inc. released FY2023 Q4 earnings on June 29 (EST) with actual revenue of 0 and EPS of -0.004

EKSO Bionics

Profusa

Antelope Enterprise

Cemtrex

FLY-E

Borealis Foods

CID Holdco

Zhongchao

ON24

Aimei Health Tech

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap